financetom
Business
financetom
/
Business
/
American Exceptionalism Acquisition Corp. A Announces Pricing of Upsized $300,000,000 Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
American Exceptionalism Acquisition Corp. A Announces Pricing of Upsized $300,000,000 Initial Public Offering
Sep 25, 2025 3:22 PM

MENLO PARK, Calif., Sept. 25, 2025 /PRNewswire/ -- American Exceptionalism Acquisition Corp. A ( AEXA ) (the "Company") announced today that it has priced its upsized initial public offering of 30,000,000 Class A ordinary shares at $10.00 per share. The Class A ordinary shares will be listed on the New York Stock Exchange ("NYSE") and trade under the ticker symbol "AEXA" beginning September 26, 2025.

The Company is led by Chamath Palihapitiya, the founder and Managing Partner of Social Capital, and is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses operating in the energy production, artificial intelligence, decentralized finance and defense industries.

Santander is acting as sole book-running manager. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 Class A ordinary shares at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained for free from the U.S. Securities and Exchange Commission (the "SEC") website http://www.sec.gov; or from Santander US Capital Markets LLC, Attention: Santander US Capital Markets LLC, 437 Madison Avenue, New York, NY 10012, by email at [email protected], or by telephone at 833-818-1602. 

The registration statement relating to the securities became effective on September 25, 2025. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's preliminary prospectus for the Company's offering filed with the SEC. Copies of these documents are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Media Contacts:

American Exceptionalism Acquisition Corp. A ( AEXA )

[email protected] 

View original content:https://www.prnewswire.com/news-releases/american-exceptionalism-acquisition-corp-a-announces-pricing-of-upsized-300-000-000-initial-public-offering-302567699.html

SOURCE American Exceptionalism Acquisition Corp. A ( AEXA )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell
United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell
May 1, 2024
08:46 AM EDT, 05/01/2024 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q1 net income Wednesday of $6.17 per diluted share, up from $4.86 a year earlier. Analysts polled by Capital IQ expected $5.66. Revenue for the quarter ended March 31 was $677.7 million, up from $506.9 million a year earlier. Analysts surveyed by Capital IQ expected $624.2 million....
BRIEF-Cps Energy Closes On Prior Announced Acquisition Of Talen Energy Gas Plants In Corpus Christi And Laredo
BRIEF-Cps Energy Closes On Prior Announced Acquisition Of Talen Energy Gas Plants In Corpus Christi And Laredo
May 1, 2024
May 1 (Reuters) - Talen Energy Corp ( TLNE ): * CPS ENERGY CLOSES ON PREVIOUSLY ANNOUNCED ACQUISITION OF TALEN ENERGY GAS PLANTS IN CORPUS CHRISTI AND LAREDO Source text for Eikon: Further company coverage: ...
Repligen's Q1 Adjusted Earnings, Revenue Fall
Repligen's Q1 Adjusted Earnings, Revenue Fall
May 1, 2024
08:47 AM EDT, 05/01/2024 (MT Newswires) -- Repligen ( RGEN ) reported Q1 adjusted earnings Wednesday of $0.28 per diluted share, down from $0.64 a year earlier. Analysts polled by Capital IQ expected $0.30. Revenue for the quarter ended March 31 was $151.3 million, down from $182.7 million a year ago. Analysts surveyed by Capital IQ expected $150.1 million. ...
Why Are Cosmetics Major Estee Lauder's Shares Diving Today?
Why Are Cosmetics Major Estee Lauder's Shares Diving Today?
May 1, 2024
Estee Lauder Companies Inc ( EL ) shares are trading lower after the company issued its third-quarter FY24 results.  The company reported a third-quarter sales growth of 5% year-on-year to $3.94 billion, beating the analyst consensus estimate of $3.913 billion. Organic net sales increased 6%, primarily due to double-digit growth in Europe, the Middle East & Africa, driven by stronger sales in Asia travel...
Copyright 2023-2026 - www.financetom.com All Rights Reserved